Related Experiment Videos
C-reactive protein, inflammation, and innate immunity
1Department of Microbiology, The Ohio State University, Columbus 43210, USA. mortensen.3@osu.edu
Immunologic Research
|October 12, 2001
Summary
C-reactive protein (CRP) is an acute phase reactant that activates complement and aids phagocytosis, linking innate and adaptive immunity. Its role in atherosclerosis requires further investigation.
Area of Science:
- Immunology
- Biochemistry
- Molecular Biology
Background:
- C-reactive protein (CRP) traditionally viewed as a nonclonal host resistance effector.
- CRP activates the classical complement cascade and mediates phagocytosis.
- CRP also regulates inflammation and provides host protection against microbial pathogens.
Purpose of the Study:
- Elucidate the molecular basis of CRP's functions, including complement activation and phosphate binding.
- Investigate the transcriptional regulation of CRP gene expression.
- Explore the role of CRP in atherosclerosis and its connection to innate and adaptive immunity.
Main Methods:
- Structural analysis of human CRP to understand molecular interactions.
- Investigation of transcription factors involved in CRP gene expression.
- Analysis of CRP's opsonic activity and Fcgamma-receptor interactions.
Main Results:
- The three-dimensional structure of CRP reveals mechanisms for complement activation and phosphate binding.
- CRP gene expression is regulated by interacting transcription factors in response to cytokines IL-1beta and IL-6.
- CRP exhibits opsonic activity, enhancing host protection against certain pathogens.
Conclusions:
- CRP is a multifaceted protein involved in both innate immunity and inflammation regulation.
- CRP's structure provides insights into its functional mechanisms.
- Further research is needed to understand CRP's role in atherosclerosis, despite its prognostic value for coronary artery disease.